Pedro Andrade Selected Research

Post-Traumatic Epilepsy (Epilepsy, Post Traumatic)

1/2021	Acute thalamic damage as a prognostic biomarker for post-traumatic epileptogenesis.
12/2020	Early Increase in Cortical T2 Relaxation Is a Prognostic Biomarker for the Evolution of Severe Cortical Damage, but Not for Epileptogenesis, after Experimental Traumatic Brain Injury.
10/2019	Harmonization of pipeline for detection of HFOs in a rat model of post-traumatic epilepsy in preclinical multicenter study on post-traumatic epileptogenesis.
10/2019	Harmonization of the pipeline for seizure detection to phenotype post-traumatic epilepsy in a preclinical multicenter study on post-traumatic epileptogenesis.
1/2019	Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis.
10/2017	Disease-modifying effect of atipamezole in a model of post-traumatic epilepsy.
1/2017	Generalized Seizures after Experimental Traumatic Brain Injury Occur at the Transition from Slow-Wave to Rapid Eye Movement Sleep.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Andrade Research Topics

Disease

10	Epilepsy (Aura) 01/2022 - 10/2015
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 10/2015
7	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 01/2021 - 01/2017
3	Seizures (Absence Seizure) 12/2021 - 01/2017
3	Allergic Contact Dermatitis 01/2013 - 02/2010
3	Melanoma (Melanoma, Malignant) 12/2007 - 02/2005
3	Neoplasms (Cancer) 12/2007 - 02/2005
1	Sleep Deprivation 05/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Infections 12/2021
1	COVID-19 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Neuroinflammatory Diseases 11/2020
1	Body Weight (Weight, Body) 01/2020
1	Brain Injuries (Brain Injury) 10/2019
1	Apnea 01/2019
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2015
1	Diabetes Mellitus 11/2012
1	Hypersensitivity (Allergy) 11/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2012
1	Pyoderma Gangrenosum 07/2012
1	Intestinal Diseases (Diseases, Intestinal) 07/2012
1	Drug Eruptions (Drug Eruption) 10/2011
1	Contact Dermatitis (Eczema, Contact) 03/2010

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	salicylhydroxamic acid (SHAM)IBA 05/2022 - 01/2018
3	Pentylenetetrazole (Metrazol)IBA 12/2021 - 10/2015
3	EpitopesIBA 12/2007 - 02/2005
3	HLA-DR Antigens (HLA-DR)IBA 12/2007 - 02/2005
3	Peptides (Polypeptides)IBA 12/2007 - 02/2005
2	IronIBA 01/2022 - 11/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2011
2	decyl glucosideIBA 01/2013 - 02/2010
2	methylene bis-benzotriazolyl tetramethylphenolIBA 01/2013 - 02/2010
2	HLA-DP Antigens (HLA-DP)IBA 12/2007 - 02/2005
2	Cancer VaccinesIBA 08/2006 - 02/2005
1	LipopolysaccharidesIBA 12/2021
1	AlbuminsIBA 11/2020
1	atipamezoleIBA 10/2017
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2015
1	Peptide Hydrolases (Proteases)FDA Link 10/2015
1	LigandsIBA 10/2015
1	Insulin (Novolin)FDA Link 11/2012
1	Immunoglobulin E (IgE)IBA 11/2012
1	Penicillins (Penicillin)FDA Link 11/2012
1	beta Lactam AntibioticsIBA 11/2012
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2011
1	AllergensIBA 03/2010
1	Dimethyl FumarateIBA 03/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	Immunodominant EpitopesIBA 08/2006
1	HLA-DPw4 antigenIBA 02/2005
1	Interleukin-5 (Interleukin 5)IBA 02/2005

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2019
1	Operative Surgical Procedures 10/2019
1	Anesthesia 01/2019
1	Electrodes (Electrode) 01/2018
1	Aftercare (After-Treatment) 10/2017
1	Restorative Proctocolectomy 07/2012
1	Immunotherapy 12/2007